Targeting Treatment Refractory NET by EZH2 Inhibition in Postural Tachycardia Syndrome

Circ Res. 2020 Apr 10;126(8):1058-1060. doi: 10.1161/CIRCRESAHA.119.315654. Epub 2020 Mar 3.
No abstract available

Keywords: epigenetic; heart rate; histone; lysine; nervous system; norepinephrine; postural tachycardia syndrome.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cells, Cultured
  • Dose-Response Relationship, Drug
  • Drug Delivery Systems / methods*
  • Enhancer of Zeste Homolog 2 Protein / antagonists & inhibitors*
  • Enhancer of Zeste Homolog 2 Protein / metabolism*
  • Heart Rate / drug effects
  • Heart Rate / physiology
  • Histone Deacetylase Inhibitors / administration & dosage
  • Humans
  • Indoles / administration & dosage
  • Norepinephrine Plasma Membrane Transport Proteins / metabolism*
  • Nylons
  • Postural Orthostatic Tachycardia Syndrome / drug therapy
  • Postural Orthostatic Tachycardia Syndrome / metabolism*
  • Pyridones / administration & dosage
  • Pyrroles / administration & dosage

Substances

  • GSK-2816126
  • Histone Deacetylase Inhibitors
  • Indoles
  • Norepinephrine Plasma Membrane Transport Proteins
  • Nylons
  • Pyridones
  • Pyrroles
  • SAHA-PIP-delta
  • SLC6A2 protein, human
  • EZH2 protein, human
  • Enhancer of Zeste Homolog 2 Protein